⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10971934 | 0.91 | — | — | |
| Tetramethylene Sulfoxide SCHEMBL27830 | 0.84 | — | — | |
| SCHEMBL6009379 | 0.80 | — | — | |
| SCHEMBL256066 | 0.80 | — | — | |
| SCHEMBL3517557 | 0.70 | — | — | |
| SCHEMBL9235 | 0.65 | — | — | |
| SCHEMBL2183477 | 0.65 | — | — | |
| SCHEMBL185670 | 0.65 | — | — | |
| SCHEMBL256058 | 0.65 | — | — | |
| SCHEMBL10172895 | 0.56 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1680 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12514251-B2 | Fused heterocyclic compounds and their use as pest control agents | PI INDUSTRIES LTD. (IN) | 2026-01-06 | — | — | US | claimed |
| US-20240335451-A1 | ACRYLAMIDE DERIVATIVES USEFUL AS ANTI-INFLAMMATORY AGENTS | SITRYX THERAPEUTICS LIMITED (GB) | 2024-10-10 | — | — | US | claimed |
| US-12107222-B2 | Liquid electrolyte comprising organic carbonates and cyclic sulfoxides for applications in lithium secondary batteries | FORSCHUNGSZENTRUM JUELICH GMBH (DE) | 2024-10-01 | — | — | US | claimed |
| EP-4359390-A1 | ACRYLAMIDE DERIVATIVES USEFUL AS ANTI-INFLAMMATORY AGENTS | Sitryx Therapeutics Limited (GB) | 2024-05-01 | — | — | EP | claimed |
| EP-4346412-A1 | FUNGICIDAL COMPOSITION CONTAINING OXADIAZOLE COMPOUNDS | PI Industries Ltd. (IN) | 2024-04-10 | — | — | EP | claimed |
| CN-111253397-B | MNK inhibitors | 上海迪诺医药科技有限公司 | 2023-11-14 | — | — | CN | claimed |
| US-20230089381-A1 | FUSED HETEROCYCLIC COMPOUNDS AND THEIR USE AS PEST CONTROL AGENTS | PI INDUSTRIES LTD. (IN) | 2023-03-23 | — | — | US | claimed |
| WO-2022269251-A1 | ACRYLAMIDE DERIVATIVES USEFUL AS ANTI-INFLAMMATORY AGENTS | SITRYX THERAPEUTICS LIMITED (GB) | 2022-12-29 | — | — | WO | claimed |
| EP-4107159-A1 | 5-(3-(ETHYLSULFONYL)PYRIDIN-2-YL)-PYRAZOLO[1,5-A]PYRIMIDINE DERIVATIVES AND RELATED COMPOUNDS AS PESTICIDE AND INSECTICIDE AGENTS FOR CROP PROTECTION | PI Industries Ltd. (IN) | 2022-12-28 | — | — | EP | claimed |
| WO-2022249074-A1 | FUNGICIDAL COMPOSITION CONTAINING OXADIAZOLE COMPOUNDS | PI INDUSTRIES LTD. (IN) | 2022-12-01 | — | — | WO | claimed |
| CN-101631792-A | Novel phosphodiesterase inhibitors | LEO PHARMA AS | 2010-01-20 | — | — | CN | claimed |
| EP-2114951-A2 | NOVEL PHOSPHODIESTERASE INHIBITORS | Leo Pharma A/S (DK) | 2009-11-11 | — | — | EP | claimed |
| US-20090215888-A1 | TOPICAL NAIL FORMULATION | NUVO RESEARCH INC. (CA) | 2009-08-27 | — | — | US | claimed |
| WO-2008104175-A2 | NOVEL PHOSPHODIESTERASE INHIBITORS | LEO PHARMA A/S (DK) | 2008-09-04 | — | — | WO | claimed |
| EP-1909772-A1 | TRANSDERMAL DRUG DELIVERY FORMULATION | Nuvo Research Inc. (CA) | 2008-04-16 | — | — | EP | claimed |
| WO-2007098591-A2 | TOPICAL NAIL FORMULATION | NUVO RESEARCH INC. (CA) | 2007-09-07 | — | — | WO | claimed |
| WO-2007016766-A1 | TRANSDERMAL DRUG DELIVERY FORMULATION | NUVO RESEARCH INC. (CA) | 2007-02-15 | — | — | WO | claimed |
| EP-1110951-B1 | PYRIMIDINE DERIVATIVES | SUMITOMO PHARMA (JP) | 2004-05-19 | — | — | EP | claimed |
| US-5476743-A | Thermoplastic resin, a charge director, a liquid component, an additive selected from cyclic carbonates, cyclic sulfones, cyclic sulfoxides and organic amides, pigments, and a charge adjuvant | XEROX CORPORATION (US) | 1995-12-19 | — | — | US | claimed |
| EP-0473387-A2 | Anti-fungal triazole derivatives, their preparation and uses | Sankyo Company Limited (JP) | 1992-03-04 | — | — | EP | claimed |